Over 406,000+
5 Star Reviews
Visits For
150+ Conditions
Open 365
Weekends & Holidays
Quick Doctor Access
No Appointments
Over 2 Million
Active Patients
Free Rx Savings Card
Get Up to 87% Off
Find Lowest Cost Rx
Check Pharmacy Prices
The Call-On-Doc Guide to Chlamydia
As one of the most common STDs alongside bacterial vaginosis, chlamydia affects well over a million people in the United States alone. Having risen year-over-year, hopes of there being a decline in cases were curbed when the number of cases went from 1,579,885 in 2020 to 1,644,416 in 2021, but fortunately, chlamydia has not returned to pre-pandemic numbers. (1)
Formally known as Chlamydia trachomatis, the STD is most common in younger generations aged 15 to 24, with an estimated 1 in 20 sexually active young women in that age group having the condition. How chlamydia has become so prevalent can be easily explained, with the majority of those infected experiencing no symptoms and going without regular and recommended STD testing.
Nov 28, 2023
The Call-On-Doc Guide to Gonorrhea
Informally known as “the clap,” gonorrhea is a sexually transmitted infection (STI) caused by the bacteria Neisseria gonorrhoeae. One of the most common STIs, second behind chlamydia, gonorrhea cases have constantly risen year over year since 2009. (1)
Due to a majority of cases going without noticeable symptoms, it's suspected that reported cases only make up a fraction of a much greater number. In addition, those who are younger and more sexually active are less likely to practice safe sex, therefore being more prone to gonorrhea transmission and may not be informed about the symptoms.
Nov 28, 2023
What is DoxyPEP?
Every year, it's estimated that around 374 million people are infected with curable sexually transmitted infections, most notably syphilis, gonorrhea, and chlamydia. (1) Just in the United States alone, the number of annual infections concerning the same STIs hovers between 1.5 million and just below 2 million. (2) Such rising numbers, alongside concerns for antibiotic resistance STDs, have driven the scientific and healthcare communities towards advancing new methods of cures and spread prevention. That’s where the recent development of DoxyPEP has made such an impact on doctors and patients alike.
Designed to function similarly to a morning-after pill, DoxyPEP is an oral antibiotic that has proven effective against immediate exposure to bacterial sexually transmitted diseases. Most effective if taken within 24 hours of exposure, DoxyPEP is also known to reduce bacterial STDs if taken within 72 hours.
Nov 28, 2023